Pyogenic liver abscess, Amoebic liver abscess .Clinical, course, diagnosis, differential diagnosis of methods of surgical treatment. Complications of parasitic diseases of the liver

Reading File

Finding Sources

Reading File

I now have comprehensive information from multiple authoritative sources. Let me compile the full answer.

Liver Abscess: Pyogenic and Amoebic — Clinical Review

I. PYOGENIC LIVER ABSCESS (PLA)

Epidemiology & Etiology

The epidemiology of PLA has shifted over the past century. In the pre-antibiotic era, it was primarily a disease of young adults secondary to appendicitis causing pylephlebitis (portal vein septic thrombosis). Today it predominantly affects patients aged 50–60 years, and biliary tract disease is the most common identifiable cause. The male:female ratio is approximately 1.5:1.

Routes of infection:

Biliary tree (most common, ~38%): cholangitis, cholelithiasis, malignant obstruction, biliary instrumentation, post-sphincterotomy, biliary-enteric anastomosis, Caroli disease
Portal vein (pylephlebitis) (~5–17%): appendicitis, diverticulitis, IBD, colorectal malignancy
Hepatic artery (hematogenous) (~3–9%): bacteremia, bacterial endocarditis
Direct extension: subphrenic abscess, penetrating peptic ulcer, perforated viscus
Trauma: blunt or penetrating
Cryptogenic (~40%): often monomicrobial Klebsiella pneumoniae; associated with occult colonic malignancy

Risk factors: diabetes mellitus, cirrhosis, malignancy, immunosuppression, liver transplant, proton pump inhibitor use, prior biliary surgery, severe periodontal disease (oral flora as a source in alcoholics).

Microbiology

Most PLAs are polymicrobial:

E. coli, Klebsiella spp., Enterococcus (biliary origin)
Bacteroides fragilis, anaerobic streptococci (enteric origin)
Streptococcus spp. (particularly S. milleri/anginosus group) — most common in US studies
Klebsiella pneumoniae — virulent strains cause cryptogenic, monomicrobial abscess, with risk of metastatic endophthalmitis (especially in diabetics)
Anaerobes (Fusobacterium necrophorum, anaerobic streptococci) increasingly identified

Clinical Features

Feature	Finding
Fever	~90% (often spiking/hectic)
Right upper quadrant pain	~60%; may radiate to right shoulder (diaphragmatic irritation)
Leukocytosis	~90%
Elevated ALP	~80%
Hyperbilirubinemia	~50%
Transaminitis	~50%
Malaise/weight loss	Common, subacute course
Jaundice	Less common; if present, suggests biliary obstruction or poor prognosis

In the pre-antibiotic era, presentation was acute with spiking fever, RUQ pain, and shock. After antibiotics, presentation became more insidious/subacute. Left untreated, mortality approaches 100%.

Diagnosis

Imaging:

CT with IV contrast — most sensitive; abscesses appear as hypoattenuated lesions, may be loculated with peripheral rim enhancement (uncommon but specific); identifies underlying cause (appendicitis, diverticulitis)
Ultrasound — preferred in pediatrics and as initial study; abscesses appear hypoechoic with possible internal echoes; less sensitive than CT
MRI — useful for further characterization and follow-up

Laboratory:

Blood cultures positive in >50% — essential for guiding antibiotic therapy
Leukocytosis, elevated ALP, bilirubin, transaminases

Aspiration/culture: Required for microbiological diagnosis and to guide therapy.

Note: Cryptogenic PLA warrants colonoscopy to exclude occult colon cancer.

Differential Diagnosis

Amoebic liver abscess
Hepatocellular carcinoma or other hepatic malignancy (necrotic center)
Echinococcal (hydatid) cyst
Hepatitis (viral, alcoholic)
Cholangitis / cholecystitis
Right lower lobe pneumonia / pulmonary abscess
Subphrenic abscess
Acute pancreatitis
Inflammatory pseudotumor of the liver
Pericardial disease (if left lobe abscess)

Key distinguishing clue: Multiple abscesses strongly favor pyogenic over amoebic etiology.

Treatment

Antibiotics

Empiric therapy covers streptococci, gram-negative bacilli, and anaerobes
Piperacillin/tazobactam monotherapy OR ceftriaxone + metronidazole
Patients with biliary instrumentation or transplant history: consider carbapenems (ESBL coverage)
IV therapy until clinical response; then oral continuation for 4–6 weeks total based on imaging follow-up

Percutaneous Catheter Drainage (PCD) — Standard of care

Recommended for any abscess >5 cm; superior outcomes vs. aspiration alone
For abscesses <3 cm: aspiration is attempted to guide antibiotic therapy; antibiotics alone may suffice
Catheters remain until output is low and clear
Success rates: 66–90%
Relative contraindications: ascites, coagulopathy, proximity to vital structures, multiple abscesses (higher failure rate but still first-line)

Percutaneous Needle Aspiration (without catheter)

Success rates ~60–90% but often requires multiple sessions (40% need 2; 20% need ≥3)
One RCT: success 60% (aspiration) vs. 100% (catheter drainage)

Surgical Drainage — Reserved for failures/special cases

Indications:

Failed percutaneous drainage
Ruptured abscess with peritonitis
Multiloculated abscess refractory to PCD
Underlying surgical pathology (appendicitis, bowel perforation) requiring operative intervention
Unresolved jaundice, renal impairment
Biliary decompression when biliary obstruction or communication present (via ERCP or transhepatic route)

Laparoscopic drainage is a feasible option in selected patients.

Liver resection is occasionally required for:

Multiple abscesses in a single lobe
Failure of drainage
Recurrent pyogenic cholangitis with extensive intrahepatic stone disease

Antibiotics alone (no drainage)

Only for patients who are not surgical candidates or refuse any invasive procedure; high mortality (59–100%) without at least partial drainage.

Complications

Intraperitoneal rupture → peritonitis (high mortality without surgery)
Empyema thoracis
Hepatobronchial fistula
Pleural or pericardial effusion
Portal vein thrombosis / Budd-Chiari syndrome (hepatic vein thrombosis)
Thoracic and abdominal fistula formation
Sepsis / multiorgan dysfunction
Metastatic septic endophthalmitis — up to 10% of diabetics with K. pneumoniae abscess
Pericardial rupture (rare)

Prognosis

Pre-antibiotic era: near 100% mortality
1945–1980s: ~50% with surgery + antibiotics
1990s–present: <10%; recent MSKCC series: 3% mortality

Poor prognostic factors: malignant disease, jaundice, hypoalbuminemia, marked leukocytosis, bacteremia, shock, abscess rupture, APACHE II score, multiorgan failure, delayed diagnosis, polymicrobial bacteremia, fungal etiology.

II. AMOEBIC LIVER ABSCESS (ALA)

Epidemiology

Caused by Entamoeba histolytica
Most common extraintestinal manifestation of amebiasis
Endemic in Mexico, India, Africa, parts of Central/South America, Southeast Asia
ALA rates <1% of symptomatic intestinal amebiasis
Strong male predominance: 10:1 male-to-female ratio (menstruating females appear protected)
Typical patient: Hispanic male, 20–40 years old, with travel/residence history in endemic area
ALA without travel history → suspect immunosuppression (HIV, malnutrition, chronic steroids)
Other risk factors: heavy alcohol use, poverty, pregnancy (abrogates female resistance), malignancy

Pathogenesis

E. histolytica exists as cysts and trophozoites:

Ingestion of cysts via fecal-oral route
Cysts become trophozoites in the colon → invade mucosa → produce flask-shaped ulcers
Trophozoites enter the portal venous circulation → reach the liver → form abscess
Beyond the liver: can establish abscesses in lung or brain

The majority of amebic infections are asymptomatic intestinal colonization; liver invasion is uncommon.

Clinical Features

Symptoms are similar to PLA and cannot reliably differentiate the two clinically:

RUQ pain, fever (nearly universal, may be intermittent), malaise, myalgias, arthralgias
Symptoms present for ~2 weeks on average at diagnosis
Latency between intestinal and hepatic infection may span years
<10% report antecedent bloody diarrhea/dysentery
Jaundice is uncommon but signifies poor prognosis
Pulmonary symptoms may be present (right-sided pleuritic features, right shoulder pain)
Occasional hepatic friction rub

Compared to PLA: ALA tends toward a more acute presentation; PLA is more subacute.

Morphology

Typically single abscess
Located in the right hepatic lobe, near the diaphragm
Contains characteristic "anchovy paste" or "chocolate sauce" material = reddish-brown necrotic hepatocytes (trophozoites rarely identified in aspirate)

Diagnosis

Imaging (US or CT) cannot distinguish ALA from PLA:

US: hypoechoic, peripheral location, rounded shape, poor rim, internal echoes
CT: peripheral low-density lesion, non-enhancing rim with peripheral edema, extension into intercostal space possible
Single abscess in right lobe near diaphragm supports ALA; multiple abscesses support PLA

Serology — cornerstone of diagnosis:

ELISA, indirect hemagglutination, latex agglutination, immunofluorescent antibody
Sensitivity ~95%, specificity >95%
90% of patients develop high-titer anti-E. histolytica antibodies
False-negatives in first 10 days of infection
Antibodies may remain elevated for years after cure (interpret in clinical context)

Stool exam: trophozoites/cysts in only ~50% of patients with ALA

PCR and amebic antigen ELISA in stool/serum: available and useful

Aspiration — indicated when:

Diagnosis remains uncertain after serology/imaging
No response to therapy after 5–7 days
Left lobe abscess close to pericardium (risk of rupture)
Pyogenic: bacteria + leukocytes in aspirate; Amebic: anchovy paste, sterile, no leukocytes

Comparison Table: PLA vs. ALA

Parameter	Pyogenic	Amoebic
Number	Often multiple	Usually single
Location	Either lobe	Right lobe, near diaphragm
Onset	Subacute	Acute
Age	50–60 years	20–40 years
Sex	M:F ~1.5:1	M:F ~10:1
Travel history	Not required	Usually endemic area
Aspirate	Pus, bacteria, leukocytes	Anchovy paste, sterile
Serology	Not diagnostic	>90% positive
Multiple abscesses	Common	Uncommon
Antibiotic treatment	Broad-spectrum IV antibiotics	Metronidazole

Differential Diagnosis of ALA

Pyogenic liver abscess (most important to distinguish)
Echinococcal (hydatid) cyst — do not aspirate if suspected
Viral hepatitis
Hepatic malignancy (necrotic HCC)
Cholangitis / cholecystitis
Right lower lobe pneumonia
Appendicitis (overlapping presentation)

Treatment

Medical (mainstay):

Metronidazole 750 mg PO TID × 7–10 days — curative in >90%
Clinical improvement typically within 72–96 hours
Alternatives: tinidazole, secnidazole (2 g × 3 days), chloroquine (less effective), emetine HCl (effective but cardiotoxic — IM injections)

Luminal amebicide (after metronidazole, to treat carrier state/prevent recurrence):

Iodoquinol 650 mg PO TID × 20 days
Paromomycin 25–35 mg/kg/day in 3 divided doses × 7–10 days
Diloxanide furoate 500 mg PO TID × 10 days

Aspiration/Drainage:

Cochrane review: no additional benefit of therapeutic aspiration over metronidazole alone for uncomplicated ALA
Indications for aspiration: diagnostic uncertainty, no response after 5–7 days, left lobe abscess near pericardium, very large abscess (>10 cm) at risk of rupture
Routine percutaneous drainage is not indicated for uncomplicated ALA (unlike PLA)

Surgical intervention: rarely required; reserved for:

Peritoneal rupture causing peritonitis
Failed percutaneous drainage in complicated cases
Thoracic rupture/empyema requiring drainage

Complications of Amoebic Liver Abscess (Parasitic Liver Disease)

Complication	Notes
Pleuropulmonary amoebiasis	Most common extraintestinal complication after liver; right-sided; can cause hepatobronchial fistula with expectoration of "anchovy paste" material
Intraperitoneal rupture	Peritonitis; managed with antimicrobials ± percutaneous drainage
Pericardial rupture	Rare but life-threatening; left lobe abscesses most at risk
Intrathoracic rupture	Empyema, right pleural effusion (fusion of diaphragm and pleura is somewhat protective)
Cerebral amoebiasis	Rare hematogenous spread
Multiorgan failure	In severe/neglected cases
Secondary bacterial infection	Co-infection with pyogenic bacteria

III. COMPLICATIONS OF OTHER PARASITIC DISEASES OF THE LIVER

Echinococcal (Hydatid) Disease

Echinococcus granulosus — cystic echinococcosis; E. multilocularis — alveolar echinococcosis
Complications: cyst rupture (anaphylaxis, daughter cyst dissemination), secondary infection, obstructive jaundice, biliary fistula, compression of hepatic vasculature
Critical: Aspiration is contraindicated if hydatid disease is suspected due to anaphylaxis risk

Hepatic Schistosomiasis

Schistosoma mansoni, S. japonicum
Portal fibrosis ("pipestem fibrosis") → portal hypertension, variceal hemorrhage, splenomegaly
Complications: hematemesis, hypersplenism, ascites

Hepatic Fascioliasis (Fasciola hepatica)

Bile duct invasion → cholangitis, biliary obstruction, eosinophilic hepatitis
Presents with fever and eosinophilia

Sources:

Current Surgical Therapy 14e, pp. 438–442
Sabiston Textbook of Surgery 7e, pp. 1884–1893
Sleisenger & Fordtran's GI and Liver Disease, pp. 1574–1735
Yamada's Textbook of Gastroenterology 7e, pp. 2178–2180

This is a shared conversation. Sign in to Orris to start your own chat.